Sales revenues for October 2018

Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for October 2018 the Company recorded a decrease of sales revenues of 16% compared to the same month of 2017, including 23% decrease of domestic sales and a decrease of 11% of export sales.

In the ten months of 2018 revenue from sales of goods decreased by 5% compared to the same period in 2017, incl. 5% decrease in sales for the domestic market and 5% decrease in export sales.